Premaitha Health PLC is engaged in molecular diagnostics business for research into, and the development and commercialization of gene analysis techniques for pre-natal screening and other clinical applications in the early detection, monitoring and treatment of disease. The Company's product, the IONA test is a non-invasive in vitro diagnostic product for prenatal screening enabling clinical laboratories to offer a regulated non-invasive prenatal test in-house. The IONA test estimates the risk of a fetus having Down's syndrome or other serious genetic diseases. The risks that fetus may be affected with include Trisomy 21 (Down's syndrome), Trisomy 18 (Edwards' syndrome), Trisomy 13 (Patau's syndrome) and Fetal sex determination optional. The analysis is performed on cell-free placental deoxyribonucleic acid (DNA) from a maternal blood sample, with test results available in three days turnaround time. The Company operates in the United Kingdom and Rest of the World.
Industry, Sector and Symbol:
- Sector: Technology
- Industry: Enterprise Software
- Sub-Industry: N/A
- Symbol: LON:NIPT
- CUSIP: N/A
- Web: www.premaitha.com/
Capitalization:- Market Cap: £18.54 million
- Outstanding Shares: 228,163,000
Average Prices:- 50 Day Moving Avg: GBX 8.51
- 200 Day Moving Avg: GBX 9.93
- 52 Week Range: GBX 7 - GBX 14.40
P/E:- Trailing P/E Ratio: N/A
- P/E Growth: 0.000
Sales & Book Value:- Annual Revenue: £3.28 million
- Price / Sales: 5.65
- Book Value: GBX (0.01) per share
- Price / Book: -13.54
Profitability:- EBIDTA: ($5,910,000.00)
- Net Margins: -245.15%
- Return on Equity: -9,579.58%
- Return on Assets: -73.52%
Misc:- Average Volume: 524,441 shs.
Frequently Asked Questions for Premaitha Health PLC (LON:NIPT)
What is Premaitha Health PLC's stock symbol?
Premaitha Health PLC trades on the London Stock Exchange (LON) under the ticker symbol "NIPT."
Where is Premaitha Health PLC's stock going? Where will Premaitha Health PLC's stock price be in 2017?
0 brokerages have issued 12-month price targets for Premaitha Health PLC's stock. Their forecasts range from GBX 18 to GBX 18. On average, they expect Premaitha Health PLC's stock price to reach GBX 18 in the next twelve months. View Analyst Ratings for Premaitha Health PLC.
Who are some of Premaitha Health PLC's key competitors?
Some companies that are related to Premaitha Health PLC include Sanderson Group plc (SND), Cerillion PLC (CER), Intercede Group plc (IGP), Bridgeline Digital (BLIN), SimiGon (SIM), Mporium Group PLC (MPOW), Advent Software (ADVS), Anite Ltd (AIE), Bos Global Holdings Ltd (FTE), Clicksoftware Technologies Ltd (CKSW), Computer Task Group (CTGX), Constant Contact (CTCT), DealerTrack Technologies (TRAK), FleetMatics Group PLC (FLTX), Gan Plc (GAME), Imprivata (IMPR), Ingenta PLC (PTO) and Innovation Group PLC (TIG).
Who are Premaitha Health PLC's key executives?
Premaitha Health PLC's management team includes the folowing people:
- Barry Kenneth Hextall, Chief Financial Officer, Director
- William Tzocor Denman IV, Executive Director
- Adam Reynolds, Non-Executive Chairman of the Board
- Alan Chang, Director
- Bill Chang, Director
- Nicholas Mustoe, Non-Executive Director
How do I buy Premaitha Health PLC stock?
Shares of Premaitha Health PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Premaitha Health PLC's stock price today?
One share of Premaitha Health PLC stock can currently be purchased for approximately GBX 8.13.
MarketBeat Community Rating for Premaitha Health PLC (LON NIPT)MarketBeat's community ratings are surveys of what our community members think about Premaitha Health PLC and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Premaitha Health PLC (LON:NIPT) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | No ratings tracked in the last 12 months. |
| Consensus Rating: | N/A (Score: NaN) |
| Consensus Price Target: | GBX 18 |
Analysts' Ratings History for Premaitha Health PLC (LON:NIPT)
Show:
| Date | Firm | Action | Rating | Price Target | Details |
|---|
| 8/24/2017 | FinnCap | Reiterated Rating | Corporate | |  |
| 7/4/2016 | Panmure Gordon | Reiterated Rating | Buy | GBX 24 | |
(Data available from 9/22/2015 forward)
Earnings History for Premaitha Health PLC (LON:NIPT)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Premaitha Health PLC (LON:NIPT)Current Year EPS Consensus Estimate: $-2.340 EPS
Dividend History for Premaitha Health PLC (LON:NIPT)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Premaitha Health PLC (LON:NIPT)Insider Trades by Quarter for Premaitha Health PLC (LON:NIPT)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 12/17/2015 | Hextall,Barry Kenneth | Insider | Buy | 180,736 | GBX 18 | £32,532.48 | |
(Data available from 1/1/2013 forward)
Headline Trends for Premaitha Health PLC (LON:NIPT)
Latest Headlines for Premaitha Health PLC (LON:NIPT)
| Source: |
|
Premaitha Health PLC (NIPT) Chart for Friday, September, 22, 2017
